JAZZ News and Press, Jazz Pharmaceuticals plc From 01/04/21

Jazz Pharmaceuticals Announces Participation in the 39th Annual J.P. Morgan Healthcare Conference PR Newswire DUBLIN , Jan. 4, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentation at...

Jazz Pharmaceuticals Announces Initiation of Biologics License Application Submission for JZP-458 for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Application to be reviewed under FDA's Oncology Center of Excellence Real-Time Oncology Review pilot prog...

After ImmunoGen shares were decimated, the company learned from its mistakes. And, they're now embarking on a path toward a spectacular turnaround. The lead medicine, Mirve, is progressing in two Phase 3 trials with a data release as early as next year. Meanwhile, other pipeline m...

Jazz Pharmaceuticals (JAZZ) along with its partner, PharmaMar announce results from the ATLANTIS Phase 3 study evaluating Zepzelca (lurbinectedin) in combination with doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine ((CAV)) for adult patients with small cell lung cance...

Jazz Pharmaceuticals and PharmaMar Announce Results of ATLANTIS Phase 3 Study Evaluating Zepzelca™ in Combination with Doxorubicin for Patients with Small Cell Lung Cancer Following One Prior Platinum-containing Line DUBLIN , Dec. 3, 2020 /PRNewswire/ -- Jazz Phar...

Jazz Pharmaceuticals Appoints Jennifer Cook and Mark Smith, M.D. to its Board of Directors Non-executive directors bring significant leadership experience and healthcare expertise PR Newswire DUBLIN, Nov. 17, 2020 DUBLIN , Nov. 17, 2020 /PRNewswire/ --&#...

As Pfizer (PFE) announced that its COVID-19 vaccine candidate is 90% effective, biotech stocks are on fire. These stocks have seen a bull-run since the beginning of 2020 and are expected to witness the same in 2021 as well. In addition to the boost from the pandemic, Jazz (JAZZ), Arrowhead (A...

Jazz Pharmaceuticals Announces Participation at Jefferies Virtual London Healthcare Conference PR Newswire DUBLIN, Nov. 10, 2020 DUBLIN , Nov. 10, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast ...

Data at ASH 2020 Annual Meeting Highlights Jazz Pharmaceuticals' Commitment to Advancing Hematology/Oncology Research 18 abstracts spanning Jazz's hematology/oncology therapeutic area to be presented Three abstracts selected for oral presentation, including long-term results...

The following slide deck was published by Jazz Pharmaceuticals plc in conjunction with their 2020 Q3 earnings call. For further details see: Jazz Pharmaceuticals plc 2020 Q3 - Results - Earnings Call Presentation